Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

See Locations Near You

Summary

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a diagnosis of malignancy

Exclusion Criteria:

Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT01148407

Recruitment Status:

Unknown status

Sponsor:

University of Vermont

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Vermont/Fletcher Allen Health Care
Burlington Vermont, 05401, United States More Info
Barbara Kelly
Contact
[email protected]
Chris E Holmes, MD PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT01148407

Recruitment Status:

Unknown status

Sponsor:


University of Vermont

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider